Worldwide Clinical Trials is uniquely experienced in the design and execution of rare disease research initiatives that embrace the evolving need for real-world evidence at all points along the drug development and commercialization continuum.
- Our Worldwide Evidence team is dedicated to the development and implementation of health economics and outcomes research, observational studies and patient registries, and patient communities in key orphan diseases.
- Often combining prospective research with innovative data sources, we balance the needs of clinical development with marketplace realities demanding the generation and communication of real-world evidence with clinical, economic, and humanistic value.
- At Worldwide, we combine our focused experience in rare diseases with our Worldwide Evidence expertise to design solutions for both regulatory approval and commercial success.
- For early-stage clients in particular, we develop strategic evidence plans to guide the inclusion of measures critical to marketplace success, while serving as an important business asset to optimize enterprise value.